Form 4: Select Medical EVP's Stock Tax Withholding

Sentiment:

Insider Transaction Report


Select Medical Holdings Corp. Executive Vice President John A. Saich reported a disposition of shares to cover tax obligations related to restricted stock vesting.

Summary

  • John A. Saich, Executive Vice President of Select Medical Holdings Corp. (SEM), reported a transaction on August 1, 2025.
  • The transaction involved the disposition of 21,745 shares of Common Stock.
  • This disposition was a surrender of shares to satisfy tax withholding obligations incident to the vesting of restricted stock.
  • The shares were valued at $12.57 per share for tax purposes.
  • Following this transaction, Saich beneficially owns 736,412 shares of Common Stock directly.

Sentiment

Score: 5

Explanation: The transaction is a routine tax-related disposition of shares upon restricted stock vesting, which is a neutral event for the company's operational performance or financial health.

Positives

  • The vesting of restricted stock indicates that the executive met performance or tenure conditions, leading to the shares becoming fully owned.

Future Outlook

This filing, a Form 4, does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

This Form 4 reports a routine insider transaction related to executive compensation and tax obligations, which is common across all industries and does not reflect broader industry trends or competitive dynamics.

Stakeholder Impact

  • Shareholders: Minimal direct impact, as this is a standard tax-related transaction for executive compensation.
  • Executive: The executive's net ownership of shares increases after the vesting, despite the tax-related disposition.

Key Dates

DateDescription
08/01/2025Date of transaction (disposition of shares for tax withholding).
08/04/2025Date the Form 4 was filed.

Recommendation

hold

This Form 4 reports a routine disposition of shares by an executive to cover tax obligations upon restricted stock vesting. It does not reflect a discretionary sale or provide new insights into the company's operational performance, financial health, or future prospects, thus not warranting a change in investment recommendation.

Keywords

Select Medical, SEM, Form 4, insider transaction, stock vesting, tax withholding, executive compensation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.